Japan Sleep Health

Japan’s growing focus on sleep health presents a timely commercial opportunity for U.S. companies with innovative medical, digital health, and consumer wellness solutions. Recent policy reforms and rising public awareness are expanding demand for sleep-related products and services, particularly in areas where U.S. firms have strong capabilities, such as digital therapeutics, remote monitoring, wearables, AI-driven analytics, and employer-focused health platforms.

Japan is increasingly positioning sleep as a national health priority. In 2024, the Ministry of Health, Labour and Welfare reinforced this focus through its “Sleep Guidelines for Health Promotion,” emphasizing adequate sleep duration and sleep quality as essential for public health. The government’s 2025 Basic Policy (“Honebuto”) further elevated sleep as a key public health issue by promoting expanded screening and treatment of sleep disorders (e.g., sleep apnea), workplace safety measures, and public awareness initiatives.

This policy focus reflects a significant national need. Japan ranks last among 38 OECD countries in average sleep duration, at just 7 hours and 22 minutes, underscoring chronic sleep deprivation as a major national challenge. In addition, regulatory changes scheduled for 2026 will allow medical institutions to designate “sleep disorders” as a clinical specialty, which is expected to improve access to care, standardize treatment, and increase patient volume.

These developments are expected to drive long-term growth in Japan’s sleep-related market. Demand is likely to expand across both medical and non-medical sectors, including diagnostics, therapeutics, digital health solutions, and employer-based sleep programs aimed at improving productivity and managing health risks. The government is also encouraging private-sector participation, positioning sleep not only as a healthcare issue but also as a growing industry opportunity. Rising consumer interest is already evident in the recovery wear market, which is projected by the Japan Management Association Research Institute to increase nearly ninefold, from $118 million (¥18.9 billion) in 2024 to $1.06 billion (¥170 billion) by 2030.

For U.S. companies, these trends create an attractive market environment. Particularly promising opportunities exist in solutions that reduce healthcare and insurance costs while leveraging data effectively, such as remote monitoring, digital therapeutics for insomnia, and enterprise-focused sleep platforms. Consumer-oriented products, including wearables and smart beds, also show strong potential as Japanese consumers increasingly invest in sleep quality and self-monitoring. 
However, success in Japan will require a thoughtful market strategy. U.S. companies should be prepared to address regulatory requirements, develop strong clinical and commercial evidence, compete with established domestic players, and manage pricing pressures associated with the weak yen. U.S. sleep technology manufacturers interested in the Japanese market are encouraged to connect with your local U.S. Commercial Service office in the United States to schedule an appointment for a consultation. In addition, the following trade shows provide valuable opportunities for market exposure.
 

• Health & Wellness Japan
  Dates: September 30 – October 2, 2026 
  Venue: Tokyo Big Sight
  Note: Health & Wellness Japan is one of Japan’s largest B2B wellness exhibitions, expected to feature approximately 460 exhibitors and attract around 36,000 visitors in 2026.
   
• Medical Japan Tokyo
  Dates: October 7 – 9, 2026
  Venue: Makuhari Messe
  Note: BioJapan is it one of Japan’s leading B2B healthcare and medical technology trade shows, expected to feature approximately 650 exhibitors and attract around 18,00 visitors in 2026.

For more information, please contact US Commercial Service Japan at Office.Tokyo@trade.gov.